Search results for "Tadalafi"

showing 6 items of 6 documents

Risultati di uno studio randomizzato singolo cieco placebo versus Diallil-Tiosulfinato, Nuciferina e Diosgenina in pazienti responders a Tadalafil 5 …

2015

The aim of the study is to evaluate the efficacy of Diallil-Tiosulphinate, Nuciepherine and Diosgenin in the treatment of erectile dysfunction. In our study were selected 120 men affected by erectile dysfunction. They were filled in a self-administered questionnaire International Index of Sexual Medicine. 74 of them reported a moderate erectile dysfunction and 46 reported a severe ED. All patients were treated with Tadalafil 5 mg once a day for 90 days. They were re-evaluated with the same questionnaire after three months of therapy. In 75% of the patients there was an improvement of IIEF-5 score. Only the 90 patients responders to Tadalafil once a day were randomized and divided into two g…

Diallil-TiosuphinateErectile DysfunctionNucipherineDiosgeninTadalafilSettore MED/24 - Urologia
researchProduct

Evaluation of an alternative dosing regimenwith tadalafil, three times per week, for men with erectile dysfunction: SURE study in Italy.

2007

AIM: To examine the preference for two dosing regimens of 20 mg of tadalafil, on demand or three times per week, in men affected with erectile dysfunction (ED) in Italy. METHODS: Scheduled Use versus on demand Regimen Evaluation (SURE) is a multicenter, crossover and open-label study, involving 94 urology centers in Italy. Patients aged 18 years or older affected with ED for at least 3 months were enrolled and randomized to 20 mg of tadalafil treatment on demand or three times per week for 5-6 weeks. After a 1-week washout, patients were crossed over to the alternate regimen for 5-6 weeks. A treatment preference question was used to determine the preferred treatment regimen. International I…

Malemedicine.medical_specialtyAlternate; Erectile dysfunction; On demand; SURE study; Tadalafil; Three times per week; Carbolines; Cross-Over Studies; Drug Administration Schedule; Erectile Dysfunction; Humans; Italy; Male; Middle Aged; Phosphodiesterase Inhibitors; Tadalafil; Treatment Outcome; Nephrology; EndocrinologyPhosphodiesterase Inhibitorserectile dysfunctionUrologyerectile dysfunction; SURE study; on demand; three times per week; alternate; tadalafilon demandDrug Administration Schedulelaw.inventionSettore MED/24 - UrologiaEndocrinologyRandomized controlled triallawOn demandInternal medicinealternateMedicineHumansClinical significanceDosingthree times per weekErectile dysfunction SURE Study on demand three times per week alternate tadalafilSURE studyCross-Over Studiesbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseCrossover studyTadalafilSurgeryRegimenErectile dysfunctionTreatment OutcomeItalyNephrologyAlternate; Erectile dysfunction; On demand; SURE study; Tadalafil; Three times per week; Carbolines; Cross-Over Studies; Drug Administration Schedule; Erectile Dysfunction; Humans; Italy; Male; Middle Aged; Phosphodiesterase Inhibitors; Tadalafil; Treatment Outcomebusinesstadalafilmedicine.drugCarbolines
researchProduct

Stroke after tadalafil use

2013

No abstract available

Malemedicine.medical_specialtyNeurologyStroke; tadalafil Phosphodiesterase inhibitorsDermatologyTadalafilInternal medicinemedicineHumansStrokeNeuroradiologymedicine.diagnostic_testCerebral infarctionbusiness.industrySettore MED/44 - Medicina Del LavoroBrainMagnetic resonance imagingGeneral MedicineMiddle AgedPhosphodiesterase 5 Inhibitorsmedicine.diseaseMagnetic Resonance ImagingTadalafilStrokePsychiatry and Mental healthSexual Dysfunction PhysiologicalSexual dysfunctionCardiologyNeurology (clinical)Neurosurgerymedicine.symptombusinesstadalafil Phosphodiesterase inhibitorsmedicine.drugCarbolines
researchProduct

VALUTAZIONE DELLA TERAPIA A LUNGO TERMINE CON TADALAFIL IN PZ CON DISFUNZIONE ERETTILE: UPDATE DOPO 6 MESI

2006

Introduzione e obiettivi Caratterizzare, in uno studio prospettico longitudinale su pazienti (pz) con disfunzione erettile (DE) trattati per 6 mesi con Tadalafil (Tad), efficacia, sicurezza, e grado di soddisfazione per il trattamento del pz e della partner. Materiali e metodi Furono arruolati 155 pz (età media 67 anni, range 26-75) con DE, mai trattati (naïve) nel 74% dei casi. La DE, presente da 2 (10%). Del piano terapeutico previsto (totale 9 m) (posologia Tad: iniziale, costante, 20 mg x 2/sett. x 6 m.; proseguimento: 20 mg x 1-2/sett. x altri 3 m. in base a risposta dei primi 6 m. e/o opzione motivata dal pz) riportiamo i dati su efficacia (IIEF5) e soddisfazione (EDITS-paziente; EDIT…

TADALAFIL DESettore MED/24 - Urologia
researchProduct

Effetti sulla disfunzione erettile dell'associazione di dialliltiosulfinato, nuciferina e diosgenina in pazienti pretrattati con inibitori della 5 fo…

2015

TadalafiDisfunzione erettileIIEF-5Settore MED/24 - Urologia
researchProduct

Evaluación de los efectos del tratamiento con tadalafilo sobre las funciones cerebrales, neurológicas y bioquímicas en pacientes con hiperplasia beni…

2015

EVALUACION DE LOS EFECTOS DEL TRATAMIENTO CON TADALAFILO SOBRE LAS FUNCIONES CEREBRALES, NEUROLOGICAS Y BIOQUIMICAS EN PACIENTES CON HBP Y DISFUNCION ERECTIL. La hiperplasia prostática benigna (HBP) es una de las enfermedades benignas más comunes en el hombre y puede derivar en una hipertrofia benigna de la próstata, en una obstrucción benigna de la próstata y/o en síntomas del tracto urinario inferior (STUI). La hiperplasia benigna de próstata suele estar asociada habitualmente con disfunción eréctil. La fisiopatología de esta enfermedad es compleja y no se conoce bien. HBP está asociada a una deficiencia en la vía de señalización NO/GMPc, inflamación y estrés oxidativo. Esta enfermedad ta…

funciones cerebralesUNESCO::CIENCIAS MÉDICASHBPdisfuncion erectiltadalafilo:CIENCIAS MÉDICAS [UNESCO]
researchProduct